These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34811496)

  • 21. Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector.
    Lucifora J; Salvetti A; Marniquet X; Mailly L; Testoni B; Fusil F; Inchauspé A; Michelet M; Michel ML; Levrero M; Cortez P; Baumert TF; Cosset FL; Challier C; Zoulim F; Durantel D
    Antiviral Res; 2017 Sep; 145():14-19. PubMed ID: 28709657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
    Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
    J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STING agonists induce an innate antiviral immune response against hepatitis B virus.
    Guo F; Han Y; Zhao X; Wang J; Liu F; Xu C; Wei L; Jiang JD; Block TM; Guo JT; Chang J
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1273-81. PubMed ID: 25512416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
    Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
    J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.
    Lutgehetmann M; Volz T; Köpke A; Broja T; Tigges E; Lohse AW; Fuchs E; Murray JM; Petersen J; Dandri M
    Hepatology; 2010 Jul; 52(1):16-24. PubMed ID: 20578126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
    Xu Z; Zhao L; Zhong Y; Zhu C; Zhao K; Teng Y; Cheng X; Chen Q; Xia Y
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):1001-1017. PubMed ID: 34896285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer.
    Feng J; Yang G; Liu Y; Gao Y; Zhao M; Bu Y; Yuan H; Yuan Y; Yun H; Sun M; Gao H; Zhang S; Liu Z; Yin M; Song X; Miao Z; Lin Z; Zhang X
    Theranostics; 2019; 9(18):5227-5245. PubMed ID: 31410212
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways.
    Liu Y; Li J; Chen J; Li Y; Wang W; Du X; Song W; Zhang W; Lin L; Yuan Z
    J Virol; 2015 Feb; 89(4):2287-300. PubMed ID: 25505063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.
    Ko C; Su J; Festag J; Bester R; Kosinska AD; Protzer U
    Antiviral Res; 2021 Oct; 194():105140. PubMed ID: 34284057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver.
    Liu Z; Wang J; Yuan H; Liu L; Bu Y; Zhao M; Yang G; Feng J; Liu Y; Li J; He Q; Zhang X
    Biochem Biophys Res Commun; 2020 Jun; 527(1):76-82. PubMed ID: 32446394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication.
    Guo Y; Li Y; Mu S; Zhang J; Yan Z
    J Med Virol; 2009 Jul; 81(7):1177-83. PubMed ID: 19475606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.
    Pollicino T; Belloni L; Raffa G; Pediconi N; Squadrito G; Raimondo G; Levrero M
    Gastroenterology; 2006 Mar; 130(3):823-37. PubMed ID: 16530522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Establishment of an HBV chronic hepatitis B infection mouse model by vivo transduction of HBV cccDNA].
    Zhao T; Li X; Yin W; Cai X; Zhang W; Chen F; Lai G; Huang A
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):260-5. PubMed ID: 25173223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human Hepatocytes.
    Zeng J; Wu D; Hu H; Young JAT; Yan Z; Gao L
    Hepatology; 2020 Dec; 72(6):1935-1948. PubMed ID: 32145089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of cccDNA in HBV Maintenance.
    Allweiss L; Dandri M
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28635668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of intrahepatic hepatitis B DNA and covalently closed circular DNA on survival after hepatectomy in HBV-associated hepatocellular carcinoma patients.
    Wang Q; Fiel MI; Luan W; Blank S; Kadri H; Kim KW; Hiotis SP
    Ann Surg Oncol; 2013 Nov; 20(12):3761-70. PubMed ID: 23771248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
    Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
    Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
    Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication.
    Liu S; Zhao K; Su X; Lu L; Zhao H; Zhang X; Wang Y; Wu C; Chen J; Zhou Y; Hu X; Wang Y; Lu M; Chen X; Pei R
    PLoS One; 2017; 12(1):e0169701. PubMed ID: 28056087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B.
    Goh ZY; Ren EC; Ko HL
    World J Gastroenterol; 2021 Apr; 27(14):1369-1391. PubMed ID: 33911462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.